The prospect of hemoglobin-based blood substitutes: Still a long stony road to go.
暂无分享,去创建一个
[1] H. Redl,et al. Influence of heme-based solutions on stress protein expression and organ failure after hemorrhagic shock* , 2005, Critical care medicine.
[2] T. Wada,et al. Paradoxical enhancement of oxidative cell injury by overexpression of heme oxygenase‐1 in an anchorage‐dependent cell ECV304 , 2004, Journal of cellular biochemistry.
[3] A. Greenburg,et al. Hemoglobin-based oxygen carriers , 2004, Critical care.
[4] E. Moore,et al. The life-sustaining capacity of human polymerized hemoglobin when red cells might be unavailable. , 2002, Journal of the American College of Surgeons.
[5] Irwin Gratz,et al. Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: results of a randomized, double-blind trial. , 2002, The Journal of thoracic and cardiovascular surgery.
[6] R. Winslow. αα–Crosslinked Hemoglobin: Was Failure Predicted by Preclinical Testing? , 2000, Vox Sanguinis.
[7] D. Gens,et al. Diaspirin Cross-Linked Hemoglobin (DCLHb) in the Treatment of Severe Traumatic Hemorrhagic Shock: A Randomized Controlled Efficacy Trial , 1999 .
[8] M. Kaste,et al. Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke. , 1999, Stroke.
[9] J. Eaton. Hemoglobin-based blood substitutes: a dream-like trade of blood and guile? , 1996, The Journal of laboratory and clinical medicine.
[10] A. Choi,et al. Hemoglobin provides protection against lethal endotoxemia in rats: the role of heme oxygenase-1. , 1995, American journal of respiratory cell and molecular biology.